BRK-B vs BRW

The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.

BRW exhibits strong deterministic health with a Piotroski F-Score of 7/9, indicating solid financial fundamentals, though the absence of an Altman Z-Score limits distress risk assessment. The stock appears deeply undervalued with a current price of $6.88 versus a Graham Number of $15.63 and an intrinsic value estimate of $38.35, suggesting significant margin of safety. However, weak technical trend (0/100), declining revenue (YoY -33.10%), and poor liquidity (Quick Ratio: 0.03) offset value appeal. High dividend yield (14.78%) is notable but raises sustainability concerns given the 77.92% payout ratio and negative operating margin.